Upper Rio Grande Basin Water Operations Review, NM; Notice of Extension, 14948 [E6-4306]

Download as PDF 14948 Federal Register / Vol. 71, No. 57 / Friday, March 24, 2006 / Notices Dated: February 24, 2006. Thomas A. Readinger, Associate Director for Offshore Minerals Management. [FR Doc. E6–4303 Filed 3–23–06; 8:45 am] DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application BILLING CODE 4310–MR–P Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on June 13, 2005, Cerilliant API Services, LLC, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed in Schedule I and II; and by letter dated September 2, 2005, to modify its name to Austin Pharma, LLC. DEPARTMENT OF THE INTERIOR Bureau of Reclamation Upper Rio Grande Basin Water Operations Review, NM; Notice of Extension Bureau of Reclamation, Interior. ACTION: Notice of extension of public comment period for thirty days. AGENCY: SUMMARY: Notice is hereby given that the comment period for the Draft Environmental Impact Statement (DEIS) for the Upper Rio Grande Water Operations Review, DES–05–80, is extended an additional 30 days to April 20, 2006. DATES: The end of the public comment period, as noted in the Federal Register (71 FR 3323) on January 20, 2006, was March 21, 2006. The public comment period is now extended to April 20, 2006. Written comments on the DEIS should be addressed to Valda Terauds, ALB–707, Bureau of Reclamation, Albuquerque Area Office, 555 Broadway, NW., Suite 100, Albuquerque, New Mexico 87102; faxogram (505) 462–3593; e-mail: vterauds@uc.usbr.gov. Our practice is to make comments, including names and home addresses of respondents, available for public review. Individual respondents may request that we withhold their home address from public disclosure, which we will honor to the extent allowable by law. If you wish us to withhold your name and/or address, you must state this prominently at the beginning of your comment. We will make all submissions from organizations or businesses, and from individuals identifying themselves as representatives or officials of organizations or businesses, available for public disclosure in their entirety. FOR FURTHER INFORMATION CONTACT: Valda Terauds, Resource Management Planner, (505) 462–3584. wwhite on PROD1PC61 with NOTICES ADDRESSES: Dated: March 7, 2006. Roger Slater, Acting Regional Director—UC Region, Bureau of Reclamation. [FR Doc. E6–4306 Filed 3–23–06; 8:45 am] Drug Schedule Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinois (7370) ..... 3,4–Methylenedioxyamphetamine (7400). 3,4–Methylenedioxy-Nethylamphetamine (7404). 3,4– Methylenedioxymethamphetamine (7405). Psilocyn (7438) ............................. Acetyldihydrocodeine (9051) ........ Benzylmorphine (9052) ................ Codeine-N-oxide (9053) ............... Cyprenorphine (9054) .................. Desomorphine (9055) ................... Etorphine (9056) ........................... Codeine methylbromide (9070) .... Dihydromorphine (9145) ............... Heroin (9200) ............................... Hydromorphinol (9301) ................. Methyldihydromorphine (9304) ..... Morphine methylbromide (9305) .. Morphine-N-oxide (9307) ............. Alphamethadol (9605) .................. Normethadone (9635) .................. Amphetamine (1100) .................... Methamphetamine (1105) ............ Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Benzoylecgonine (9180) ............... Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Levomethorphan (9210) ............... Methadone (9250) ........................ Methadone intermediate (9254) ... Morphine (9300) ........................... Thebaine (9333) ........................... Levo-alphacetylmethadol (9648) .. Oxymorphone (9652) ................... Poppy Straw Concentrate (9670) Alfentanil (9737) ........................... Remifentanil (9739) ...................... Sufentanil (9740) .......................... Carfentanil (9743) ......................... Fentanyl (9801) ............................ BILLING CODE 4310–MN–P VerDate Aug<31>2005 18:26 Mar 23, 2006 Jkt 208001 PO 00000 Frm 00117 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk manufacture a synthetic THC (7370). No other activity for this drug code is authorized for this registration. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than May 23, 2006. Dated: March 20, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–4302 Filed 3–23–06; 8:45 am] BiLLiNG CODE 4410–09–P DEPARTMENT OF LABOR Office of the Secretary Submission for OMB Review: Comment Request March 17, 2006. The Department of Labor (DOL) has submitted the following public information collection requests (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). A copy of each ICR, with applicable supporting documentation, may be obtained by contacting Darrin King on 202–693– 4129 (this is not a toll-free number) or e-mail: king.darrin@dol.gov. Comments should be sent to Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Occupational Safety and Health Administration (OSHA), Office of Management and Budget, Room 10235, Washington, DC 20503, 202–395–7316 E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 71, Number 57 (Friday, March 24, 2006)]
[Notices]
[Page 14948]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4306]


-----------------------------------------------------------------------

DEPARTMENT OF THE INTERIOR

Bureau of Reclamation


Upper Rio Grande Basin Water Operations Review, NM; Notice of 
Extension

AGENCY: Bureau of Reclamation, Interior.

ACTION: Notice of extension of public comment period for thirty days.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the comment period for the Draft 
Environmental Impact Statement (DEIS) for the Upper Rio Grande Water 
Operations Review, DES-05-80, is extended an additional 30 days to 
April 20, 2006.

DATES: The end of the public comment period, as noted in the Federal 
Register (71 FR 3323) on January 20, 2006, was March 21, 2006. The 
public comment period is now extended to April 20, 2006.

ADDRESSES: Written comments on the DEIS should be addressed to Valda 
Terauds, ALB-707, Bureau of Reclamation, Albuquerque Area Office, 555 
Broadway, NW., Suite 100, Albuquerque, New Mexico 87102; faxogram (505) 
462-3593; e-mail: vterauds@uc.usbr.gov. Our practice is to make 
comments, including names and home addresses of respondents, available 
for public review. Individual respondents may request that we withhold 
their home address from public disclosure, which we will honor to the 
extent allowable by law. If you wish us to withhold your name and/or 
address, you must state this prominently at the beginning of your 
comment. We will make all submissions from organizations or businesses, 
and from individuals identifying themselves as representatives or 
officials of organizations or businesses, available for public 
disclosure in their entirety.

FOR FURTHER INFORMATION CONTACT: Valda Terauds, Resource Management 
Planner, (505) 462-3584.

    Dated: March 7, 2006.
Roger Slater,
Acting Regional Director--UC Region, Bureau of Reclamation.
[FR Doc. E6-4306 Filed 3-23-06; 8:45 am]
BILLING CODE 4310-MN-P